Logo for uniQure N.V.

uniQure Investor Relations Material

Latest events

Logo for uniQure N.V.

Study Update

uniQure
Logo for uniQure

Q4 2023

28 Feb, 2024
Logo for uniQure

Study Update

19 Dec, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from uniQure N.V.

Access all reports
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Through its adeno-associated virus (AAV) based gene therapy platform, the company develops proprietary power gene therapies that can be used to treat diseases with a high unmet need. Its lead program is focused on Hemophilia B and Huntington's disease.